Advertisement

Citation tools

Rousselot, Philippe et al "Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years." Blood 109.1 (2007): 58-60. Web. 15 Sept2019.